Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1993 Jan;68(1):85-7.
doi: 10.1136/adc.68.1.85.

Prevention of viral induced asthma attacks using inhaled budesonide

G Connett  1 , W Lenney
Affiliations
Clinical Trial

Prevention of viral induced asthma attacks using inhaled budesonide

G Connett et al. Arch Dis Child. 1993 Jan.

Abstract

Thirty two preschool children were entered into a double blind, placebo controlled study using intermittent budesonide to treat viral induced wheeze. Active treatment was either 800 micrograms twice a day via a spacer or 1600 micrograms twice a day via a spacer and facemask in those children too young to use a mouthpiece. Treatment was started at the onset of an upper respiratory tract infection and continued for seven days or until symptoms had resolved for 24 hours. Each child remained in the study until they had completed using one pair of budesonide and placebo inhalers in random order without the need for additional oral prednisolone. Twenty five children completed 28 treatment pairs. All 25 families were asked to express a preference after completing their first treatment pair: 12 preferred budesonide and six preferred placebo; seven had no preference. Symptom scores were compared in 17 treatment pairs that were completed without the need for oral prednisolone. Mean day and night time wheeze in the first week after infection were significantly lower in those receiving budesonide. Intermittent inhalation of budesonide can modify the severity of wheezing in preschool children developing asthma after viral respiratory infections but improvements were modest with the doses used in this study.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Arch Dis Child. 1984 Apr;59(4):310-15 - PubMed
    1. Br Med J (Clin Res Ed). 1986 Jul 19;293(6540):169-71 - PubMed
    1. Lancet. 1987 Apr 18;1(8538):879-82 - PubMed
    1. Arch Dis Child. 1987 Apr;62(4):345-8 - PubMed
    1. Pediatrics. 1988 May;81(5):624-9 - PubMed

Publication types